Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
City of Hope Medical Center
City of Hope Medical Center
Pfizer
PrECOG, LLC.
Institut Paoli-Calmettes
Fudan University
University of Washington
Sichuan University
Krystal Biotech, Inc.
University Hospital, Essen
Sun Yat-sen University
Second Affiliated Hospital of Guangzhou Medical University